LmxMPK4, an essential mitogen-activated protein kinase of Leishmania mexicana is phosphorylated and activated by the STE7-like protein kinase LmxMKK5

International Journal for Parasitology

Volumn 40, Issue 8, 2010, Pages 969-978

  John von Freyend, Simona ^a   Rosenqvist, Heidi ^a   Fink, Annette ^b   Melzer, Inga Maria ^b   Clos, Joachim ^b   Jensen, Ole Nørregaard ^c   Wiese, Martin ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Co expression; Drug target; Leishmania mexicana; MAP2K; Mitogen activated protein kinase

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOTRANSFERASE; PROTEIN LMXMKK5; PROTEIN LMXMPK4; PROTEIN TXY; RECOMBINANT ENZYME; RECOMBINANT PROTEIN; STAUROSPORINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AMINO ACID; ASSAY; DRUG; MASS SPECTROMETRY; MOLECULAR ECOLOGY; PROTEIN; RADIOMETER;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PHOSPHORYLATION; ENZYME PURIFICATION; IMMUNOBLOTTING; IN VITRO STUDY; LEISHMANIA MEXICANA; LEISHMANIASIS; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN MOTIF; RADIOMETRY; SCHISTOSOMIASIS; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; DNA, PROTOZOAN; ESCHERICHIA COLI; GENE EXPRESSION; IMMUNOBLOTTING; LEISHMANIA MEXICANA; MASS SPECTROMETRY; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PHOSPHORYLATION; PHYLOGENY; PROTEIN INTERACTION MAPPING; PROTEIN KINASE INHIBITORS; PROTOZOAN PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; STAUROSPORINE;

ESCHERICHIA COLI; LEISHMANIA MEXICANA;

EID: 77953023801     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.02.004     Document Type: Article

References (51)

1. Agron P.G., Reed S.L., Engel J.N. An essential, putative MEK kinase of Leishmania major. Mol. Biochem. Parasitol. 2005, 142:121-125.
2. Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat. Biotechnol. 2006, 24:1285-1292.
3. Benzel I., Weise F., Wiese M. Deletion of the gene for the membrane-bound acid phosphatase of Leishmania mexicana. Mol. Biochem. Parasitol. 2000, 111:77-86.
4. Bunkoczi G., Salah E., Filippakopoulos P., Fedorov O., Muller S., Sobott F., Parker S.A., Zhang H., Min W., Turk B.E., Knapp S. Structural and functional characterization of the human protein kinase ASK1. Structure 2007, 15:1215-1226.
5. Chang L., Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
6. Clos J., Brandau S. PJC20 and pJC40 - two high-copy-number vectors for T7 RNA polymerase-dependent expression of recombinant genes in Escherichia coli. Protein Expr. Purif. 1994, 5:133-137.
7. Cohen P. Targeting protein kinases for the development of anti-inflammatory drugs. Curr. Opin. Cell Biol. 2009, 21:317-324.
8. Crews C.M., Alessandrini A., Erikson R.L. The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product. Science 1992, 258:478-480.
9. Dell K.R., Engel J.N. Stage-specific regulation of protein phosphorylation in Leishmania major. Mol. Biochem. Parasitol. 1994, 64:283-292.
10. El Sayed N.M., Myler P.J., Blandin G., Berriman M., Crabtree J., Aggarwal G., Caler E., Renauld H., Worthey E.A., Hertz-Fowler C., Ghedin E., Peacock C., Bartholomeu D.C., Haas B.J., Tran A.N., Wortman J.R., Alsmark U.C., Angiuoli S., Anupama A., Badger J., Bringaud F., Cadag E., Carlton J.M., Cerqueira G.C., Creasy T., Delcher A.L., Djikeng A., Embley T.M., Hauser C., Ivens A.C., Kummerfeld S.K., Pereira-Leal J.B., Nilsson D., Peterson J., Salzberg S.L., Shallom J., Silva J.C., Sundaram J., Westenberger S., White O., Melville S.E., Donelson J.E., Andersson B., Stuart K.D., Hall N. Comparative genomics of trypanosomatid parasitic protozoa. Science 2005, 309:404-409.
11. Erdmann M., Scholz A., Melzer I.M., Schmetz C., Wiese M. Interacting protein kinases involved in the regulation of flagellar length. Mol. Biol. Cell. 2006, 17:2035-2045.
12. Eyers P.A., Craxton M., Morrice N., Cohen P., Goedert M. Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. Chem. Biol. 1998, 5:321-328.
13. Featherstone C., Russell P. Fission yeast p107wee1 mitotic inhibitor is a tyrosine/serine kinase. Nature 1991, 349:808-811.
14. Grewal S., Molina D.M., Bardwell L. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo. Cell Signal. 2006, 18:123-134.
15. Guan K.L., Dixon J.E. Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal. Biochem. 1991, 192:262-267.
16. Hanks S.K., Hunter T. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 1995, 9:576-596.
17. Ivens A.C., Peacock C.S., Worthey E.A., Murphy L., Aggarwal G., Berriman M., Sisk E., Rajandream M.A., Adlem E., Aert R., Anupama A., Apostolou Z., Attipoe P., Bason N., Bauser C., Beck A., Beverley S.M., Bianchettin G., Borzym K., Bothe G., Bruschi C.V., Collins M., Cadag E., Ciarloni L., Clayton C., Coulson R.M., Cronin A., Cruz A.K., Davies R.M., De Gaudenzi J., Dobson D.E., Duesterhoeft A., Fazelina G., Fosker N., Frasch A.C., Fraser A., Fuchs M., Gabel C., Goble A., Goffeau A., Harris D., Hertz-Fowler C., Hilbert H., Horn D., Huang Y., Klages S., Knights A., Kube M., Larke N., Litvin L., Lord A., Louie T., Marra M., Masuy D., Matthews K., Michaeli S., Mottram J.C., Muller-Auer S., Munden H., Nelson S., Norbertczak H., Oliver K., O'neil S., Pentony M., Pohl T.M., Price C., Purnelle B., Quail M.A., Rabbinowitsch E., Reinhardt R., Rieger M., Rinta J., Robben J., Robertson L., Ruiz J.C., Rutter S., Saunders D., Schafer M., Schein J., Schwartz D.C., Seeger K., Seyler A., Sharp S., Shin H., Sivam D., Squares R., Squares S., Tosato V., Vogt C., Volckaert G., Wambutt R., Warren T., Wedler H., Woodward J., Zhou S., Zimmermann W., Smith D.F., Blackwell J.M., Stuart K.D., Barrell B., Myler P.J. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442.
18. Johnson G.L., Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002, 298:1911-1912.
19. Kuhn D., Wiese M. LmxPK4, a mitogen-activated protein kinase kinase homologue of Leishmania mexicana with a potential role in parasite differentiation. Mol. Microbiol. 2005, 56:1169-1182.
20. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and Clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
21. Le Pape P. Development of new antileishmanial drugs - current knowledge and future prospects. J. Enzyme Inhib. Med. Chem. 2008, 23:708-718.
22. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Heys J.R., Landvatter S.W. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
23. Ligterink W., Hirt H. Mitogen-activated protein (MAP) kinase pathways in plants: versatile signaling tools. Int. Rev. Cytol. 2001, 201:209-275.
24. Lindberg R.A., Quinn A.M., Hunter T. Dual-specificity protein kinases: will any hydroxyl do?. Trends Biochem. Sci. 1992, 17:114-119.
25. Maltezou H.C. Drug resistance in visceral leishmaniasis. J. Biomed. Biotechnol. 2010, 2010:617521.
26. Melikant B., Giuliani C., Halbmayer-Watzina S., Limmongkon A., Heberle-Bors E., Wilson C. The Arabidopsis thaliana MEK AtMKK6 activates the MAP kinase AtMPK13. FEBS Lett. 2004, 576:5-8.
27. Menegay H.J., Myers M.P., Moeslein F.M., Landreth G.E. Biochemical characterization and localization of the dual specificity kinase CLK1. J. Cell Sci. 2000, 113:3241-3253.
28. Morales M.A., Renaud O., Faigle W., Shorte S.L., Spath G.F. Over-expression of Leishmania major MAP kinases reveals stage-specific induction of phosphotransferase activity. Int. J. Parasitol. 2007, 37:1187-1199.
29. Ohren J.F., Chen H., Pavlovsky A., Whitehead C., Zhang E., Kuffa P., Yan C., McConnell P., Spessard C., Banotai C., Mueller W.T., Delaney A., Omer C., Sebolt-Leopold J., Dudley D.T., Leung I.K., Flamme C., Warmus J., Kaufman M., Barrett S., Tecle H., Hasemann C.A. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat. Struct. Mol. Biol. 2004, 11:1192-1197.
30. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127:635-648.
31. Page R.D. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 1996, 12:357-358.
32. Pages G., Brunet A., L'Allemain G., Pouyssegur J. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1). EMBO J. 1994, 13:3003-3010.
33. Parsons M., Worthey E.A., Ward P.N., Mottram J.C. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi. BMC Genomics 2005, 6:127.
34. Rappsilber J., Ishihama Y., Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 2003, 75:663-670.
35. Reithinger R., Dujardin J.C. Molecular diagnosis of leishmaniasis: current status and future applications. J. Clin. Microbiol. 2007, 45:21-25.
36. Rijal S., Chappuis F., Singh R., Bovier P.A., Acharya P., Karki B.M., Das M.L., Desjeux P., Loutan L., Koirala S. Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:350-354.
37. Ruegg U.T., Burgess G.M. Staurosporine, K-252 and UCN-01: potent but non-specific inhibitors of protein kinases. Trends Pharmacol. Sci. 1989, 10:218-220.
38. Schluter A., Wiesgigl M., Hoyer C., Fleischer S., Klaholz L., Schmetz C., Clos J. Expression and subcellular localization of cpn60 protein family members in Leishmania donovani. Biochim. Biophys. Acta 2000, 1491:65-74.
39. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68:850-858.
40. Sindermann H., Engel J. Development of miltefosine as an oral treatment for leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 2006, 100(Suppl. 1):S17-S20.
41. Sundar S., Mehta H., Suresh A.V., Singh S.P., Rai M., Murray H.W. Amphotericin B treatment for Indian visceral leishmaniasis: conventional versus lipid formulations. Clin. Infect. Dis. 2004, 38:377-383.
42. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., Kumar P.C., Murray H.W. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 2000, 31:1104-1107.
43. Tanoue T., Nishida E. Molecular recognitions in the MAP kinase cascades. Cell Signal. 2003, 15:455-462.
44. Thingholm T.E., Larsen M.R. The use of titanium dioxide micro-columns to selectively isolate phosphopeptides from proteolytic digests. Methods Mol. Biol. 2009, 527:57-66.
45. Wang Q., Melzer I.M., Kruse M., Sander-Juelch C., Wiese M. LmxMPK4, a mitogen-activated protein (MAP) kinase homologue essential for promastigotes and amastigotes of Leishmania mexicana. Kinetoplastid. Biol. Dis. 2005, 4:6.
46. Wiese M. A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host. EMBO J. 1998, 17:2619-2628.
47. Wiese M. Leishmania MAP kinases-familiar proteins in an unusual context. Int. J. Parasitol. 2007, 37:1053-1062.
48. Wilson K.P., McCaffrey P.G., Hsiao K., Pazhanisamy S., Galullo V., Bemis G.W., Fitzgibbon M.J., Caron P.R., Murcko M.A., Su M.S. The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 1997, 4:423-431.
49. Zhang F., Strand A., Robbins D., Cobb M.H., Goldsmith E.J. Atomic structure of the MAP kinase ERK2 at 2.3Å resolution. Nature 1994, 367:704-711.
50. Zhou T., Raman M., Gao Y., Earnest S., Chen Z., Machius M., Cobb M.H., Goldsmith E.J. Crystal structure of the TAO2 kinase domain: activation and specificity of a Ste20p MAP3K. Structure 2004, 12:1891-1900.
51. Zilberstein D., Shapira M. The role of pH and temperature in the development of Leishmania parasites. Annu. Rev. Microbiol. 1994, 48:449-470.